Inovio Pharmaceuticals Stock Falls After Pricing Offering

Dow Jones

Jul 03, 2025

By Kelly Cloonan

Shares of Inovio Pharmaceuticals declined after the company disclosed the pricing of an underwritten public offering for shares of its common stock.

The stock fell 38% to $1.33 on Thursday. Shares are down 84% in the past 12 months.

The biotechnology company will offer about 14.3 million common shares for $1.75 apiece.

Underwriters have been granted a 30-day option to purchase up to an additional 2.1 million shares at the public offering price, the company said.

Inovio expects the offering to generate gross proceeds of about $25 million.

The offering is expected to close on July 7, subject to customary closing conditions.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

July 03, 2025 11:47 ET (15:47 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2548838655"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548838655\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548838655?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-03 23:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548838655","market":"fut","top_or_hot":-1,"title":"Inovio Pharmaceuticals Stock Falls After Pricing Offering","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By <a href=\"https://laohu8.com/S/KELYA\">Kelly</a> Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a> declined after the company disclosed the pricing of an underwritten public offering for shares of its common stock. \n</p>\n<p>\n  The stock fell 38% to $1.33 on Thursday. Shares are down 84% in the past 12 months. \n</p>\n<p>\n  The biotechnology company will offer about 14.3 million common shares for $1.75 apiece. \n</p>\n<p>\n  Underwriters have been granted a 30-day option to purchase up to an additional 2.1 million shares at the public offering price, the company said. \n</p>\n<p>\n  Inovio expects the offering to generate gross proceeds of about $25 million. \n</p>\n<p>\n  The offering is expected to close on July 7, subject to customary closing conditions. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to <a href=\"https://laohu8.com/S/KELYB\">Kelly</a> Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 11:47 ET (15:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Stock Falls After Pricing Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Stock Falls After Pricing Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-03 23:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By <a href=\"https://laohu8.com/S/KELYA\">Kelly</a> Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a> declined after the company disclosed the pricing of an underwritten public offering for shares of its common stock. \n</p>\n<p>\n  The stock fell 38% to $1.33 on Thursday. Shares are down 84% in the past 12 months. \n</p>\n<p>\n  The biotechnology company will offer about 14.3 million common shares for $1.75 apiece. \n</p>\n<p>\n  Underwriters have been granted a 30-day option to purchase up to an additional 2.1 million shares at the public offering price, the company said. \n</p>\n<p>\n  Inovio expects the offering to generate gross proceeds of about $25 million. \n</p>\n<p>\n  The offering is expected to close on July 7, subject to customary closing conditions. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to <a href=\"https://laohu8.com/S/KELYB\">Kelly</a> Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 11:47 ET (15:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2548838655","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548838655","pubTimestamp":1751557620,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Inovio Pharmaceuticals declined after the company disclosed the pricing of an underwritten public offering for shares of its common stock.The stock fell 38% to $1.33 on Thursday. Shares are down 84% in the past 12 months.The biotechnology company will offer about 14.3 million common shares for $1.75 apiece.Underwriters have been granted a 30-day option to purchase up to an additional 2.1 million shares at the public offering price, the company said.Inovio expects the offering to generate gross proceeds of about $25 million.The offering is expected to close on July 7, subject to customary closing conditions.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","BK4568":"美国抗疫概念","BK4139":"生物科技","INO":"伊诺维奥制药"},"translate_title":"Inovio Pharmaceuticals股价在定价发行后下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INO":1},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  Shares of Inovio Pharmaceuticals declined after the company disclosed the pricing of an underwritten public offering for shares of its common stock. \n\n\n  The stock fell 38% to $1.33 on Thursday. Shares are down 84% in the past 12 months. \n\n\n  The biotechnology company will offer about 14.3 million common shares for $1.75 apiece. \n\n\n  Underwriters have been granted a 30-day option to purchase up to an additional 2.1 million shares at the public offering price, the company said. \n\n\n  Inovio expects the offering to generate gross proceeds of about $25 million. \n\n\n  The offering is expected to close on July 7, subject to customary closing conditions. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 03, 2025 11:47 ET (15:47 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}